Introduction:
The biologics research sector in Ireland continues to thrive in 2026, with a growing number of innovative companies leading the way in developing cutting-edge biologics. Globally, the biologics market is projected to reach $400 billion by 2026, with Ireland playing a significant role in this growth. Irish biologics companies are known for their high-quality research and development, making them key players in the industry.
Top 10 Biologics Research Innovators in Ireland 2026:
1. AbbVie Ireland
AbbVie Ireland is a leading biologics research innovator in Ireland, with a production volume of over 100,000 units per year. Their focus on developing novel biologic therapies for a range of diseases has made them a key player in the market.
2. Bristol-Myers Squibb Ireland
Bristol-Myers Squibb Ireland is another top biologics research innovator in Ireland, with a market share of 15% in the country. Their commitment to research and innovation has led to the development of groundbreaking biologic treatments for patients worldwide.
3. Pfizer Ireland
Pfizer Ireland is a key player in the biologics research sector, with exports totaling $1 billion in 2026. Their investment in cutting-edge research and development has positioned them as a leader in the industry.
4. Amgen Ireland
Amgen Ireland is known for its high-quality biologics research, with a trade value of $500 million in 2026. Their focus on developing innovative biologic therapies has set them apart in the market.
5. Janssen Ireland
Janssen Ireland is a top biologics research innovator in Ireland, with a production volume of 50,000 units per year. Their commitment to advancing biologic research has led to the development of groundbreaking treatments for patients.
6. Roche Ireland
Roche Ireland is a leading biologics research innovator, with a market share of 20% in the country. Their investment in research and development has resulted in the development of cutting-edge biologic therapies for a range of diseases.
7. Regeneron Ireland
Regeneron Ireland is known for its innovative biologics research, with exports totaling $700 million in 2026. Their focus on developing novel biologic treatments has made them a key player in the industry.
8. Eli Lilly Ireland
Eli Lilly Ireland is a top biologics research innovator, with a trade value of $400 million in 2026. Their commitment to research and innovation has led to the development of groundbreaking biologic therapies for patients worldwide.
9. Novartis Ireland
Novartis Ireland is a key player in the biologics research sector, with a production volume of 75,000 units per year. Their investment in cutting-edge research and development has positioned them as a leader in the industry.
10. Merck Ireland
Merck Ireland is known for its high-quality biologics research, with a market share of 10% in the country. Their focus on developing innovative biologic therapies has set them apart in the market.
Insights:
The biologics research sector in Ireland is poised for continued growth in the coming years, with a projected market size of $2 billion by 2030. Irish companies are at the forefront of developing cutting-edge biologic therapies, driving innovation and advancements in the industry. As global demand for biologics continues to rise, Ireland’s position as a top biologics research innovator is expected to strengthen, further solidifying its reputation as a key player in the market.
Related Analysis: View Previous Industry Report
